 |
 |
|
|
|
| Noopept |
 |
| Noopept |
 |
| 157115-85-0 |
 |
Noopept
(Skype:sales09_109)
Product Description:
CAS No.: 157115-85-0
Molecular Formula: C17H22N2O4
Molecular Weight: 318.37
Purity:99%
Appearance: White off-white crystalline powder
Storage: Store in well-closed container, protec...
Application: The product is used as chemical reage.....
Description:
Noopept is considered a nootropic drug with neuroprotective properties. It is reported to improve learning ability and memory (including the initial processing of information, consolidation, and retrieval). It is also used to prevent the development of amnesia induced by electroshock.
It has also been observed to reverse and prevent learned helplessness neurosis in rats after long term (21 day) treatment.
Applications:
It is derived from the racetam family of drugs and shares similar mechanisms of action, but is, according to studies, 1000 times more potent than the prototypical racetam drug, piracetam.[4]Animal studies have shown noopept to be neuroprotective and enhance memory in various tests. Since it is a peptide-derived compound, noopept is degraded by enzymes in the GI tract and liver. Its oral bioavailability has been shown to be much lower than other routes of administration, with serum concentrations reaching 10% of IV levels per-orally. It does show good blood-brain barrier penetration[11] in rats (although a previous study concluded that "GVS-111 itself was not found in rat brain 1 h after 5 mg/kg i.p. administration up to limit of detection" and that administration of Noopept only increases the concentration of endogenous nootropic cyclo-L-prolylglycine[3]), and human studies have shown promising results, with potential application in the treatment of Alzheimer's disease.[12] It is also an "immunocorrector" in mice.[13] Noopept attenuates apoptosis and tau hyperphosphorylation in an animal model of Alzheimer disease. [14]
Email:sales09 at ycphar dom com
Skype:sales09_109
Telephone:86-027-50756084
Mobile:86-18872220656
|
 |
Noopept
(Skype:sales09_109)
Product Description:
CAS No.: 157115-85-0
Molecular Formula: C17H22N2O4
Molecular Weight: 318.37
Purity:99%
Appearance: White off-white crystalline powder
Storage: Store in well-closed container, protec...
Application: The product is used as chemical reage.....
Description:
Noopept is considered a nootropic drug with neuroprotective properties. It is reported to improve learning ability and memory (including the initial processing of information, consolidation, and retrieval). It is also used to prevent the development of amnesia induced by electroshock.
It has also been observed to reverse and prevent learned helplessness neurosis in rats after long term (21 day) treatment.
Applications:
It is derived from the racetam family of drugs and shares similar mechanisms of action, but is, according to studies, 1000 times more potent than the prototypical racetam drug, piracetam.[4]Animal studies have shown noopept to be neuroprotective and enhance memory in various tests. Since it is a peptide-derived compound, noopept is degraded by enzymes in the GI tract and liver. Its oral bioavailability has been shown to be much lower than other routes of administration, with serum concentrations reaching 10% of IV levels per-orally. It does show good blood-brain barrier penetration[11] in rats (although a previous study concluded that "GVS-111 itself was not found in rat brain 1 h after 5 mg/kg i.p. administration up to limit of detection" and that administration of Noopept only increases the concentration of endogenous nootropic cyclo-L-prolylglycine[3]), and human studies have shown promising results, with potential application in the treatment of Alzheimer's disease.[12] It is also an "immunocorrector" in mice.[13] Noopept attenuates apoptosis and tau hyperphosphorylation in an animal model of Alzheimer disease. [14]
Email:sales09 at ycphar dom com
Skype:sales09_109
Telephone:86-027-50756084
Mobile:86-18872220656
|
|
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
